BioPharm International
CONTINUE TO SITE >

OR WAIT 15 SECS

V. Premnath

V. Premnath is head, NCL Innovations at CSIR-NCL and director, Venture Center, Pune, India.

Articles

A Systematic Evaluation of Risks and Mitigation Strategies for Convalescent Plasma Therapy for COVID-19

A task force details its findings of the risks associated with using convalescent plasma using failure mode and effects analysis